OMIC — Singular Genomics Systems Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Singular Genomics Systems, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	46.2	26.9	340	245	175
Net Total Accounts Receivable
Net Total Receivables	—	—	—	0.913	0.565
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	46.5	27.6	348	268	192
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.61	2.37	6.07	56.7	71.5
Other Long Term Assets
Total Assets	48.2	30.5	356	328	265
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.11	3.69	6.74	14.1	18.3
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3.69	12.9	19.5	67.7	86.5
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	44.5	17.6	336	260	179
Total Liabilities & Shareholders' Equity	48.2	30.5	356	328	265
Total Common Shares Outstanding